Triclabendazole was first used to treat Fasciola hepatica infections in animals in the early 1980s. It has established itself as the primary anti-fluke medication on the market due to its strong action against immature flukes.
Triclabendazole Market: Introduction
- Triclabendazole was first used to treat Fasciola hepatica infections in animals in the early 1980s. It has established itself as the primary anti-fluke medication on the market due to its strong action against immature flukes. Triclobendazole has recently been used to treat human cases of fascioliasis; and currently, it is the treatment of choice for this infection as well.
Read Report Overview - https://www.transparencymarketresearch.com/triclabendazole-market.html
- Triclabendazole became a generic drug because patents in many countries expired in the late 1990s. During that time, a lot of products were created. In the early 2000s, Agrovet Market Animal Health introduced Trivantel 15, a 15% triclabendazole suspension. Agrovet Market Animal Health also developed and launched the first triclabendazole injectable solution (in combination with ivermectin) in 2009. Fasiject Plus, a 36% triclabendazole and 0.6% ivermectin solution; is utilized to treat Fasciola hepatica (both immature and adult liver flukes), roundworms, and ectoparasite infections.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_82892
Key Drivers, Restrains, and Opportunities of Global Triclabendazole Market
- Increase in prevalence of fascioliasis is driving the triclabendazole market. Fascioliasis is a foodborne trematode infection with a worldwide distribution. Fasciola infection has been reported in 81 countries, and is considered a neglected zoonotic disease by the World Health Organization. Two accepted species, Fasciola hepatica and Fasciola gigantica, infect a wide range of mammals including livestock and humans. It was estimated that between 2.6 million people were infected around the world with Fascioliasis. Given the emerging character of fascioliasis and reports of its expanding endemic areas, it is likely that the number of infections around the world surpasses previous estimates.
Request for Analysis of COVID-19 Impact on Triclabendazole Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_82892
- Fascioliasis is found in focal areas of more than 70 countries, in all continents except Antarctica. It is found in parts of Latin America, the Caribbean, Europe, the Middle East, Africa, Asia, and Oceania. Fasciola gigantica is found in fewer geographic regions. Human cases have been reported in the tropics, in parts of Africa and Asia, and also in Hawaii. Triclabendazole is indicated for the treatment of fascioliasis in patients aged 6 years old and above, which drives its market.
- Governments of developing countries are making significant investments to modernize healthcare infrastructure, which is likely to increase access to health care. This is expected to increase the demand for Triclabendazole. Increase in prevalence of Fascioliasis in developing countries presents lucrative opportunities for the global Triclabendazole market.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_82892
North America to Capture Major Share of Global Triclabendazole Market
- North America is expected to account for major share of the global Triclabendazole market due to high prevalence of Fascioliasis among the population. Moreover, well-established healthcare infrastructure and hub for key industry players are major factors boosting the Triclabendazole market in the region.
- The Triclabendazole market in Asia Pacific is estimated to expand at a rapid pace during the forecast period owing to expansion of health care infrastructure. Moreover, surge in Fascioliasis infection is likely propel the market in the region.
Pre Book Triclabendazole Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_82892<ype=S
Key Players Operating in Global Triclabendazole Market
The global Triclabendazole market is highly concentrated due to the presence of key players. A large number of manufacturers hold major share in their respective regions. Demand for products to treat Fascioliasis has increased in emerging as well as developed markets. Growth strategies adopted by leading players are likely to drive the global Triclabendazole market.
More Trending Reports by Transparency Market Research:
Neurovascular Embolization Devices (Neurology) Market Healthcare companies in the neurovascular embolization devices (neurology) market have successfully established a strong foundation for treatment options with the help of embolization coils and liquid embolic systems. However, these treatment options present unique challenges in certain health conditions such as wide-neck bifurcated aneurysms.
Endoscopic Vessel Harvesting Systems Market The premium placed on hygiene and cleanliness, of both, the setting in which a surgery takes place and the implements used, has been in the spotlight due to rise in the rate of infections owing to the use of reusable components and implements. The reusable components of endoscopic vessel harvesting system accessories, such as the dissector and harvester units, have been steadily losing popularity in recent years due to the elevated risk of cross contamination and complications arising from infections.
Cardiac Output Monitoring Devices Market Technological advancements have enabled continuous real-time cardiac output (CO) monitoring in lithium dilution technique. This technique is projected to witness exponential growth in the cardiac output monitoring devices market during the forecast period. Lithium dilution (LiD) is known to exhibit good correlation with the pulmonary artery catheter (PAC) thermodilution technique in hyperdynamic conditions.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/